Stay updated on QL1706 Combo in Adjuvant Stage II-III NSCLC Clinical Trial
Sign up to get notified when there's something new on the QL1706 Combo in Adjuvant Stage II-III NSCLC Clinical Trial page.

Latest updates to the QL1706 Combo in Adjuvant Stage II-III NSCLC Clinical Trial page
- Check7 days agoChange DetectedAdded a new record history revision entry (v3.4.3) and removed the previous entry (v3.4.2).SummaryDifference0.1%

- Check14 days agoChange DetectedVersion 2 (2024-10-10) updates the Recruitment Status and Locations in the study record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.4.2 was added to the history, and the entry for v3.4.1 was removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedA new revision entry (Revision: v3.4.1) was added to the record history. Older entries, including a funding-status notice and Revision: v3.4.0, were removed.SummaryDifference0.9%

- Check42 days agoChange DetectedA general notice about a lapse in government funding and the NIH's operating status was added to the page, informing users that information may not be up to date and where to find status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check49 days agoChange DetectedThe Record History page now shows a glossary toggle, color-coded change indicators (green for additions, red for deletions), and updated revision labeling (e.g., Revision: v3.4.0). These updates clarify how changes are presented without affecting the underlying trial data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to QL1706 Combo in Adjuvant Stage II-III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QL1706 Combo in Adjuvant Stage II-III NSCLC Clinical Trial page.